Ugur Sahin

Chief Executive Officer at BIONTECH SE

Net worth: 3 845 M $ as of 31/05/2026

60 year

50 connections

Commercial Services

Health Technology

Consumer Services

Profile

Founder of BioNTech SE, Ganymed Pharmaceuticals AG, Ci3 Management UG and TRON - Translationale Onkologie an der Universitätsmedizin der, Ugur Sahin currently is Chief Executive Officer for BioNTech SE and Managing Director at reBOOST Management GmbH (a subsidiary of BioNTech SE) and Managing Director at Medine GmbH. Dr. Sahin is also Professor at Universitätsmedizin der Johannes Gutenberg-Universität Mainz. He previously occupied the position of Chief Medical Officer for Ganymed Pharmaceuticals AG and Co-Managing Director at TRON - Translationale Onkologie an der Universitätsmedizin der. Dr. Sahin received a doctorate from Universität zu Köln.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
BIONTECH SE 16.59%	31/03/2026	40,076,320 ( 16.59% )	3 845 M $	31/05/2026

Latest news about Ugur Sahin

05-05	BioNTech to close sites in Germany, Singapore affecting 1,860 staff	RE
03-11	AlphaValue Says Investor Reaction to BioNTech Was Excessive
03-10	Co-founders Ugur Sahin and Ozlem Tureci behind pioneering Covid vaccine to step down from BioNTech - FT	RE
03-10	Ugur Sahin and Özlem Türeci are leaving German group BioNTech to launch their own mRNA venture - FT	RE
04/11/24	BioNTech lowers full-year revenue outlook on COVID-19 seasonality, inventory write-downs	RE

Ugur Sahin active positions

Companies	Position	Start
BIONTECH SE	Chief Executive Officer	02/06/2008
reBOOST Management GmbH reBOOST Management GmbH Miscellaneous Commercial ServicesCommercial Services Provides management consultancy services	Chief Executive Officer	23/10/2018
Medine GmbH Medine GmbH Miscellaneous Commercial ServicesCommercial Services Provides management consultancy services	Chief Executive Officer	14/03/2011
Universitätsmedizin der Johannes Gutenberg-Universität Mainz Universitätsmedizin der Johannes Gutenberg-Universität Mainz Medical/Nursing ServicesHealth Services Provides health care facilities and services	Corporate Officer/Principal	01/01/2014
Helmholtz Institute For Translational Oncology	Corporate Officer/Principal	-
BioNTech Delivery Technologies GmbH BioNTech Delivery Technologies GmbH Miscellaneous Commercial ServicesCommercial Services Engages in research and development of immunotherapies	Chief Executive Officer	-

All active positions of Ugur Sahin

Former positions of Ugur Sahin

Companies	Position	End
TRON - Translationale Onkologie an der Universitätsmedizin der TRON - Translationale Onkologie an der Universitätsmedizin der Miscellaneous Commercial ServicesCommercial Services Operates as biopharmaceutical research organization	Chief Executive Officer	01/01/2019
Ganymed Pharmaceuticals AG Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Develops antibodies for the treatment of solid cancers	Founder	30/07/2010
Ci3 Management UG	Founder	-

See the detail of Ugur Sahin's experience

Training of Ugur Sahin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ugur Sahin's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Ganymed Pharmaceuticals AG Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Develops antibodies for the treatment of solid cancers	Health Technology
Universität zu Köln Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
BioNTech SE BioNTech SE BiotechnologyHealth Technology Develops immunotherapies and mRNA-based vaccines to treat cancer & infectious diseases	Health Technology
Universitätsmedizin der Johannes Gutenberg-Universität Mainz Universitätsmedizin der Johannes Gutenberg-Universität Mainz Medical/Nursing ServicesHealth Services Provides health care facilities and services	Health Services
Ci3 Management UG
TRON - Translationale Onkologie an der Universitätsmedizin der TRON - Translationale Onkologie an der Universitätsmedizin der Miscellaneous Commercial ServicesCommercial Services Operates as biopharmaceutical research organization	Commercial Services
Medine GmbH Medine GmbH Miscellaneous Commercial ServicesCommercial Services Provides management consultancy services	Commercial Services
reBOOST Management GmbH reBOOST Management GmbH Miscellaneous Commercial ServicesCommercial Services Provides management consultancy services	Commercial Services
BioNTech Delivery Technologies GmbH BioNTech Delivery Technologies GmbH Miscellaneous Commercial ServicesCommercial Services Engages in research and development of immunotherapies	Commercial Services
Helmholtz Institute For Translational Oncology